$40.01 0.00 (%) Baxter International Inc - NYSE

Jul. 30, 2015 | 04:00 PM

Partner Headlines

  1. Benzinga's Top Downgrades

    Benzinga | Jul. 7, 2015 | 09:29AM EST
  2. Unusual Call Activity In Baxter

    Benzinga | Jul. 7, 2015 | 08:12AM EST
  3. Benzinga's Top Downgrades

    Benzinga | Jul. 2, 2015 | 09:32AM EST
  4. Baxter Shares Bid Up Ahead Of Spinoff

    IBD | Jun. 25, 2015 | 18:30PM EST
  5. US Stock Futures Surge Ahead Of Jobless Claims

    Benzinga | Jun. 25, 2015 | 08:10AM EST
  6. U.S. FDA Grants Priority Review for MM-398 New Drug Application

    Benzinga | Jun. 25, 2015 | 07:05AM EST
  7. Goldman Sachs Initiates Baxter International With Buy

    Benzinga | Jun. 24, 2015 | 10:50AM EST
  8. Benzinga's Top Initiations

    Benzinga | Jun. 24, 2015 | 09:59AM EST
  9. Baxalta Reports Continued Progress on Phase 1/2 Clinical Trial of BAX335, Investigational Gene Therapy Treatment for Hemophilia B

    Benzinga | Jun. 24, 2015 | 09:01AM EST
  10. Baxter Announces Effectiveness of Baxalta Form 10 Registration Statement

    Benzinga | Jun. 9, 2015 | 17:04PM EST
  11. Baxter and Baxalta Holdings Outline Vision for Accelerated and Sustainable Growth, Showcase Innovation

    Benzinga | May. 18, 2015 | 08:35AM EST
  12. Baxter buying leukemia drugs

    IBD | May. 12, 2015 | 19:01PM EST
  13. Take Steps To Become The Best You

    IBD | Apr. 28, 2015 | 14:41PM EST
  14. Akorn Downgraded, Stock Falls On 'Credibility Gap'

    IBD | Apr. 27, 2015 | 11:26AM EST
  15. Baxter

    IBD | Apr. 23, 2015 | 18:31PM EST
  16. Earnings Scheduled For April 23, 2015

    Benzinga | Apr. 23, 2015 | 04:03AM EST
  17. Cyberonics Soars On Earnings Beat, Tax Inversion Deal

    IBD | Feb. 26, 2015 | 13:58PM EST
  18. To Reinvest or Not Reinvest: That is the Question

    GuruFocus | Feb. 19, 2015 | 09:55AM EST
  19. Best Stock Pick For Long Term Investors

    GuruFocus | Feb. 10, 2015 | 14:40PM EST
  20. Richard Pzena's New Buys

    GuruFocus | Feb. 9, 2015 | 14:43PM EST
  21. Richard Pzena's 5 New Q4 Stock Buys

    GuruFocus | Feb. 7, 2015 | 00:56AM EST
  22. Baxter Int'l

    IBD | Jan. 29, 2015 | 18:38PM EST
  23. Earnings Scheduled For January 29, 2015

    Benzinga | Jan. 29, 2015 | 04:45AM EST
  24. Baxter Offers Yield In Hot Medical Products Group

    IBD | Jan. 16, 2015 | 17:47PM EST
  25. What Investors Are Expecting Ahead Of Multiple Nektar Therapeutics Catalysts

    Benzinga | Jan. 9, 2015 | 12:53PM EST
  26. Spinal Products Firm NuVasive Ripe For Expansion

    IBD | Jan. 8, 2015 | 15:17PM EST
  27. What Investors Should Expect From Rockwell Medical's Next FDA Decision

    Benzinga | Jan. 7, 2015 | 16:22PM EST
  28. Pete Najarian's Picks For 2015: Citigroup, Foot Locker And More

    Benzinga | Jan. 6, 2015 | 17:20PM EST
  29. What Investors Are Looking for After Seeing Unusual Options Activity In Halozyme

    Benzinga | Jan. 6, 2015 | 12:15PM EST
  30. Inogen Powers Up Medical Products Stocks With Oxygen

    IBD | Jan. 5, 2015 | 16:37PM EST
  31. Baxter Submits Application for U.S. FDA Approval of BAX111, Investigational Recombinant Treatment for Von Willebrand Disease

    Benzinga | Dec. 22, 2014 | 09:00AM EST
  32. Baxter Reports Filing of Form 10 Registration Statement Related to Planned Spinoff of Biopharma Unit

    Benzinga | Dec. 10, 2014 | 17:16PM EST
  33. Pfizer Spreading Its Wings Into A New Domain Of Life Sciences

    GuruFocus | Dec. 9, 2014 | 10:50AM EST
  34. Hot Drugmakers Build More Labs, Grab Space In Boston

    IBD | Dec. 4, 2014 | 16:47PM EST
  35. I think Zimmer Will Outperform S&P 500 Performance

    GuruFocus | Dec. 4, 2014 | 10:06AM EST
  36. Becton, Dickinson and Co. (BDX) Dividend Stock Analysis

    GuruFocus | Nov. 19, 2014 | 12:37PM EST
  37. Baxter tops in Q3 amid split-up

    IBD | Oct. 16, 2014 | 18:49PM EST
  38. Baxter Q3 Beats As Hemophilia Drugs Fend Off Rivals

    IBD | Oct. 16, 2014 | 15:07PM EST
  39. Earnings Scheduled For October 16, 2014

    Benzinga | Oct. 16, 2014 | 04:50AM EST
  40. UPDATE: Morgan Stanley Reiterates On Baxter International On Value Creation Through Spin

    Benzinga | Oct. 13, 2014 | 09:34AM EST
  41. UPDATE: Bank Of America Reiterates On Baxter International Inc. On Mixed Factors

    Benzinga | Oct. 6, 2014 | 07:40AM EST
  42. Baxter Gets Shot In The Arm From Rockwell Deal

    IBD | Oct. 3, 2014 | 18:09PM EST
  43. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 3, 2014 | 08:44AM EST
  44. Medical Technology Company Offers Investment Opportunity

    GuruFocus | Sep. 25, 2014 | 16:00PM EST
  45. Stocks Gain While Dollar Reaches Highest Level Since 2010

    Benzinga | Sep. 24, 2014 | 17:03PM EST
  46. Dow Jumps 170 Points; Bed Bath & Beyond Shares Rise On Upbeat Results

    Benzinga | Sep. 24, 2014 | 15:54PM EST
  47. U.S. Stocks Rise; Accenture Shares Decline On Weak Forecast

    Benzinga | Sep. 24, 2014 | 13:17PM EST
  48. Markets Edge Lower; KB Home Posts Downbeat Results

    Benzinga | Sep. 24, 2014 | 10:49AM EST
  49. Morning Market Movers

    Benzinga | Sep. 24, 2014 | 09:40AM EST
  50. Baxter And Merrimack Pharmaceuticals Enter Into Exclusive Ex-U.S. Licensing Agreement to Develop And Commercialize Novel Cancer Compound MM-398

    Benzinga | Sep. 24, 2014 | 07:01AM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!